The increase in price target by RBC Capital suggests a positive outlook on PTC Therapeutics' stock performance in the short term. This adjustment reflects an analyst's confidence in the company's potential to reach or exceed the new target, likely due to favorable developments or expectations within the company or its market. Such endorsements can positively influence investor sentiment and potentially lead to an increase in stock price.